HLA-C and COVID-19: The lack of adequate small animal models to assess immunogenicity of human T-cell epitopes makes the development of COVID-19 T cell-based vaccines very challenging, resembling the hurdles researchers have encountered in testing epitope-based universal influenza vaccines [69], as the available transgenic animals usually express only one MHC allele, which may not reflect the real diversity of the human population.